Vertex Pharmaceuticals (1VRTX) Q3 2019 Earnings Report
IT:1VRTX Q3 2019 EPS Results
- Actual EPS
- EUR 1.10
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- EUR 0.97
IT:1VRTX Q3 2019 Revenue Results
- Actual Revenue
- EUR 838.43M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +20.02%
Earnings Announcement Details
- Quarter
- Q3 2019
- Date
- 10/30/2019
- Time
- After Close
- Conference Call
- Wednesday, October 30, 2019
IT:1VRTX Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for November 2, 2026, based on past reporting schedules.
Q3 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
IT:1VRTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 02, 2026 | 2026 (Q3) | 4.30- | 4.28 | ― | ― |
| Aug 03, 2026 | 2026 (Q2) | 4.234.22 | 4.03 | 4.65% (+0.19) | |
| May 04, 2026 | 2026 (Q1) | 3.793.99 | 3.62 | 10.10% (+0.37) | |
| Feb 12, 2026 | 2025 (Q4) | 4.564.49 | 3.55 | 26.38% (+0.94) | |
| Nov 03, 2025 | 2025 (Q3) | 4.084.28 | 3.91 | 9.59% (+0.37) | |
| Aug 06, 2025 | 2025 (Q2) | 3.834.03 | -11.45 | 135.23% (+15.48) | |
| May 05, 2025 | 2025 (Q1) | 3.853.62 | 4.25 | -14.71% (-0.62) | |
| Feb 10, 2025 | 2024 (Q4) | 3.583.55 | 3.75 | -5.24% (-0.20) | |
| Nov 04, 2024 | 2024 (Q3) | 3.643.91 | 3.64 | 7.35% (+0.27) | |
| Aug 01, 2024 | 2024 (Q2) | -10.38-11.45 | 3.47 | -429.82% (-14.92) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed